Your browser doesn't support javascript.
loading
Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children.
Escherich, Carolin; Chen, Wenan; Li, Yizhen; Yang, Wenjian; Nishii, Rina; Li, Zhenhua; Raetz, Elizabeth A; Devidas, Meenakshi; Wu, Gang; Nichols, Kim E; Inaba, Hiroto; Pui, Ching-Hon; Jeha, Sima; Camitta, Bruce M; Larsen, Eric; Hunger, Stephen P; Loh, Mignon L; Yang, Jun J.
Affiliation
  • Escherich C; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Chen W; Department for Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany.
  • Li Y; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Yang W; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Nishii R; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Li Z; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Raetz EA; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Devidas M; Department of Pediatrics and Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.
  • Wu G; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Nichols KE; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Inaba H; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Pui CH; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Jeha S; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Camitta BM; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Larsen E; Department of Pediatrics, Midwest Center for Cancer and Blood Disorders, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hunger SP; Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME, USA.
  • Loh ML; Department of Pediatrics and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Yang JJ; Seattle Children's Hospital, the Ben Towne Center for Childhood Cancer Research, University of Washington, Seattle, WA, USA.
Res Sq ; 2023 Jul 21.
Article in En | MEDLINE | ID: mdl-37503171
ABSTRACT
Biallelic mutation in the DNA-damage repair gene NBN is the genetic cause of Nijmegen Breakage Syndrome, which is associated with predisposition to lymphoid malignancies. Heterozygous carriers of germline NBN variants may also be at risk for leukemia development, although this is much less characterized. We systematically examined the frequency of germline NBN variants in pediatric B-ALL and identified 25 putatively damaging NBN coding variants in 50 of 4,183 B-ALL patients. Compared with the frequency of NBN variants in 118,479 gnomAD non-cancer controls we found significant overrepresentation in pediatric B-ALL (p=0.004, OR=1.77). Most B-ALL-risk variants were missense and cluster within the NBN N-terminal domains. Using two functional assays, we verified 14 of 25 variants with severe loss-of-function phenotypes and thus classified these as pathogenic or likely pathogenic. Finally, we found that heterozygous germline NBN variant carriers showed similar survival outcomes relative to those with WT status. Taken together, our findings provide novel insights into the genetic predisposition to B-ALL, the impact of NBN variants on protein function and suggest that heterozygous NBN variant carriers may safely receive B-ALL therapy.

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2023 Type: Article